Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

Budd-Chiari syndrome and non-cirrhotic non-tumoral portal vein thrombosis are 2 rare
disorders, with several similarities that are categorized under the term splanchnic vein …

These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the
management of portal hypertension have been commissioned by the Clinical Services and …

Budd Chiari syndrome (BCS) is a diverse disease with regard to the site of obstruction, the
predisposing thrombophilic disorders and clinical presentation across the Asia-Pacific …

Budd–Chiari syndrome (BCS) is an uncommon condition, caused by obstruction to hepatic
venous outflow. It is largely underdiagnosed, and a high index of suspicion is required for …

Abstract Background Budd–Chiari syndrome (BCS) is a rare disease characterized by
hepatic venous outflow tract obstruction (HVOTO). Methods Recent literature has been …

Background Budd-Chiari syndrome (BCS) is an eponym that includes a group of conditions
characterized by partial or complete hepatic venous tract outflow obstruction, and the site of …

Summary Background Budd‐Chiari syndrome (BCS) is a rare but fatal disease caused by
obstruction in the hepatic venous outflow tract. Aim To provide an update of the …

This study was performed to evaluate the outcome of endovascular intervention therapy for
Budd-Chiari syndrome (BCS) and compare recanalization, transjugular intrahepatic …

Purpose To assess the critical role of transjugular intrahepatic portosystemic shunt (TIPS) in
the management of Budd-Chiari syndrome (BCS), as the data with respect to the safety and …